Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals.
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane Review deemed most relevant to practising healthcare professionals. The evidence is displayed in a user-friendly tabulated format that includes narratives, data, and links to graphics.
CCAs are available with a Cochrane Library subscription or national license. The following CCAs will be free until 30th November 2019:
- What are the effects of rufinamide as an adjunct to conventional antiepileptic drug (AED) therapy for people with refractory epilepsy?
- What are the benefits and harms of oral immunotherapy for children and adolescents with egg allergy?
- What are the effects of iodine supplementation for women during pregnancy and postpartum and for their children?
- How do volume expanders compare with placebo/no treatment for preventing ovarian hyperstimulation syndrome?
- How does acetaminophen (paracetamol) compare with other interventions for preterm or low birth weight infants with patent ductus arteriosus (PDA)?
Get involved: The clinical answer is written either by a practicing clinician or by a CCA Editor, with the answer being peer-reviewed by a practicing clinician. If you would like to join the Clinical Answers authoring team, please contact the team at email@example.com. We are specifically looking for clinicians in the following areas: respiratory medicine; care of the elderly; cardiovascular medicine; pregnancy and childbirth; neurology - especially epilepsy; infectious disease; paediatrics; rheumatology; ENT; and urology.